Vera Therapeutics Stock Price Down 4.6 percent Heres Why
VERA Stock | USD 21.71 0.32 1.45% |
About 60% of Vera Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Vera Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Vera Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Vera Therapeutics stock news signals to limit their universe of possible portfolio assets.
Vera Therapeutics, Inc. s stock price fell 4.6 percent during trading on Monday . The company traded as low as 44.00 and last traded at 44.13. 217,934 shares traded hands during mid-day trading, a decline of 76 percent from the average session volume of 907,844 shares. The stock had previously closed at 46.26.
Read at thelincolnianonline.com
![]() |
Vera Therapeutics Fundamental Analysis
We analyze Vera Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vera Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vera Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Vera Therapeutics is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Vera Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Vera Therapeutics stock to make a market-neutral strategy. Peer analysis of Vera Therapeutics could also be used in its relative valuation, which is a method of valuing Vera Therapeutics by comparing valuation metrics with similar companies.
Peers
Vera Therapeutics Related Equities
VTYX | Ventyx Biosciences | 5.98 | ||||
EWTX | Edgewise Therapeutics | 1.24 | ||||
ALDX | Aldeyra | 0.93 | ||||
CGEM | Cullinan Oncology | 0.91 | ||||
ADAG | Adagene | 0.63 | ||||
TYRA | Tyra Biosciences | 0.20 | ||||
THRD | Third Harmonic | 0.19 | ||||
ANAB | AnaptysBio | 0.05 | ||||
CNTB | Connect Biopharma | 1.25 | ||||
XLO | Xilio Development | 1.39 | ||||
TVTX | Travere Therapeutics | 2.05 | ||||
CYTK | Cytokinetics | 2.40 | ||||
ANEB | Anebulo Pharmaceuticals | 2.80 | ||||
GLUE | Monte Rosa | 3.08 | ||||
ETON | Eton Pharmaceuticals | 3.12 | ||||
RLYB | Rallybio Corp | 3.33 | ||||
COGT | Cogent Biosciences | 3.41 | ||||
ACRV | Acrivon Therapeutics, | 4.07 | ||||
TARS | Tarsus Pharmaceuticals | 5.05 | ||||
MLYS | Mineralys Therapeutics, | 6.15 | ||||
RAPT | RAPT Therapeutics | 6.25 |
Complementary Tools for Vera Stock analysis
When running Vera Therapeutics' price analysis, check to measure Vera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vera Therapeutics is operating at the current time. Most of Vera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Vera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vera Therapeutics' price. Additionally, you may evaluate how the addition of Vera Therapeutics to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |